ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,276Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 393

$518K Total Retail Price of All Prescriptions

Rank: 56 out of 393

431 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 431 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

19% of this provider’s 431 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 7,022 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 559 407 1 2
HYDROCODONE-ACETAMINOPHEN 426 279 S3 2 5
OMEPRAZOLE 319 241 3 6
SIMVASTATIN 301 251 4 1
LEVOTHYROXINE SODIUM 292 216 5 3
GABAPENTIN 259 165 6 15
FUROSEMIDE 232 166 7 8
CARVEDILOL 220 147 8 21
AMLODIPINE BESYLATE 216 162 9 4
METFORMIN HCL 211 174 10 7
ALENDRONATE SODIUM 210 187 11 16
TRAMADOL HCL 172 114 12 30
HYDROCHLOROTHIAZIDE 162 137 13 10
PRAVASTATIN SODIUM 160 131 14 18
LOVASTATIN 147 114 15 14
CYCLOBENZAPRINE HCL 146 76 R 16 109
MORPHINE SULFATE ER 129 63 S2 17 48
LOSARTAN POTASSIUM 125 113 18 12
ZOLPIDEM TARTRATE 123 77 19 11
TRAZODONE HCL 106 41 20 47
MELOXICAM 105 70 21 58
SPIRIVA 104 87 22 41
CITALOPRAM HBR 97 67 23 23
EVISTA 93 91 24 98
METHYLPREDNISOLONE 91 69 25 80
SERTRALINE HCL 89 74 26 28
FINASTERIDE 84 52 27 60
ADVAIR DISKUS 82 58 28 53
ATORVASTATIN CALCIUM 82 55 28 19
PAROXETINE HCL 80 57 30 61
AZITHROMYCIN 79 54 31 35
ATENOLOL 78 69 32 13
WARFARIN SODIUM 77 55 33 17
PROAIR HFA 77 59 33 68
KLOR-CON M20 77 64 33 137
FAMOTIDINE 76 28 36 70
FLUOXETINE HCL 75 54 37 37
TIZANIDINE HCL 74 43 38 97
POTASSIUM CHLORIDE 71 60 39 20
AMITRIPTYLINE HCL 70 15 R 40 72
LISINOPRIL-HYDROCHLOROTHIAZIDE 68 55 41 24
TRIAMTERENE-HCTZ 68 48 41 49
VENTOLIN HFA 63 39 43 42
FELODIPINE ER 62 41 44 130
OXYCODONE-ACETAMINOPHEN 59 41 S2 45 71
LANTUS SOLOSTAR 57 37 46 74
OXYBUTYNIN CHLORIDE 56 41 47 90
OXYCODONE HCL 55 13 S2 48 36
SYNTHROID 54 47 49 44
FENOFIBRATE 54 25 49 43
CYMBALTA 54 23 49 88
METOPROLOL TARTRATE 51 36 52 9
MIRTAZAPINE 50 23 53 89
GLYBURIDE 50 27 R 53 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.